[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Asia Pacific Fluorescence In-Situ Hybridization (Fish) Imaging Systems Market Forecast to 2030 – Regional Analysis – By Product (Instruments, Consumables, Accessories, and Software), Application (Cancer Diagnosis, Genetic Disease Diagnosis, Infectious Disease Diagnostic, and Others), and End User (Diagnostic Laboratories, Contract Research Organizations, Pharmaceutical and Biotechnological Companies, and Others)

January 2024 | 106 pages | ID: AEF679AA8AA6EN
The Insight Partners

US$ 3,550.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The Asia Pacific fluorescence in-situ hybridization (FISH) imaging systems market is expected to grow from US$ 217.6 million in 2022 to US$ 400.9 million by 2030. It is estimated to grow at a CAGR of 7.9% from 2022 to 2030.
Increasing R&D Investments in In-Vitro Diagnostics Fuel Asia Pacific Fluorescence In-Situ Hybridization (Fish) Imaging Systems Market
The Asia Pacific Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market is driven by continued investments in research and development (R&D) activities related to in-vitro diagnostics (IVD). With its unique capability to visualize specific DNA sequences within cellular environments, the FISH technique has emerged as a key procedure in the modern diagnostics ecosystem, particularly in detecting genetic disorders and rare diseases. An upsurge in R&D funding in IVD has catalyzed transformative advancements in FISH imaging systems by allowing researchers to create cutting-edge platforms providing enhanced image quality with features supporting streamlined automation, culminating in more accurate and rapid diagnostic processes. PNA FISH, a novel diagnostic method that uses FISH with peptide nucleic acid (PNA) probes, combines the ease of traditional staining procedures with the exceptional performance of PNA probes to provide rapid and accurate diagnoses of contagious diseases, which makes PNA FISH suitable for routine application and enables clinical microbiology laboratories to report important information for patient therapy within a time frame that is not possible using classic biochemical methods.
Asia Pacific Fluorescence In-Situ Hybridization (Fish) Imaging Systems Market Overview
The Asia Pacific Asia Pacific Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market is expected to register the highest CAGR during the forecast period. The regional market is expected to grow rapidly in the coming years due to factors such as high cancer prevalence rates in countries, government initiatives to improve the medical device industry, and robust medical device manufacturing. Delivery centers in Indonesia, India, and China typically support outsourcing services in this region. Additionally, the rising cases of genetic disorders and infectious diseases significantly expand the Asia Pacific Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market growth in Asia Pacific.
Asia Pacific Fluorescence In-Situ Hybridization (Fish) Imaging Systems Market Revenue and Forecast to 2030 (US$ Million)
Asia Pacific Fluorescence In-Situ Hybridization (Fish) Imaging Systems Market Segmentation
The Asia Pacific fluorescence in-situ hybridization (FISH) imaging systems market is segmented into product, application, end users and country.
Based on product, the Asia Pacific fluorescence in-situ hybridization (FISH) imaging systems market is segmented into instruments, consumables, accessories, and software. The consumables segment held the largest share of the Asia Pacific fluorescence in-situ hybridization (FISH) imaging systems market in 2022.
In terms of application, the Asia Pacific fluorescence in-situ hybridization (FISH) imaging systems market is segmented into cancer diagnosis, genetic disease diagnosis, infectious disease diagnostic, and others. The cancer diagnosis segment held the largest share of the Asia Pacific fluorescence in-situ hybridization (FISH) imaging systems market in 2022.
Based on end user, the Asia Pacific fluorescence in-situ hybridization (FISH) imaging systems market is segmented into diagnostic laboratories, contract research organizations, pharmaceutical and biotechnological companies, and others. The diagnostic laboratories segment held the largest share of the Asia Pacific fluorescence in-situ hybridization (FISH) imaging systems market in 2022.
By country, the Asia Pacific fluorescence in-situ hybridization (FISH) imaging systems market is segmented int o China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific. The China dominated the Asia Pacific fluorescence in-situ hybridization (FISH) imaging systems market in 2022.
Euroclone SpA, Tissuegnostics Gmbh, Agilent Technologies Inc, Abnova Taiwan Corp, Biogenex Laboratories Inc, Leica Biosystems Nussloch Gmbh, Metasystems Probes Gmbh, Bio-View Ltd, And Thermo Fisher Scientific Inc are some of the leading companies operating in the Asia Pacific fluorescence in-situ hybridization (FISH) imaging systems market.
1. INTRODUCTION

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation

2. EXECUTIVE SUMMARY

2.1 Key Insights

3. RESEARCH METHODOLOGY

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. ASIA PACIFIC FLUORESCENCE IN-SITU HYBRIDIZATION (FISH) IMAGING SYSTEMS MARKET - KEY INDUSTRY DYNAMICS

4.1 Key Market Drivers:
  4.1.1 Rising Prevalence of Target Disorders
  4.1.2 Increasing R&D Investments in In-Vitro Diagnostics
4.2 Key Market Restraints:
  4.2.1 High Cost of FISH Imaging Systems and Procedures
4.3 Key Market Opportunities:
  4.3.1 Technological Advancements in Fluorescence in Situ Hybridization Imaging
4.4 Future Trends:
  4.4.1 Automation and Digitalization of FISH Imaging Technique
4.5 Impact Analysis:

5. FLUORESCENCE IN-SITU HYBRIDIZATION (FISH) IMAGING SYSTEMS MARKET - ASIA PACIFIC MARKET ANALYSIS

5.1 Asia Pacific Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market Revenue (US$ Mn), 2022 – 2030

6. ASIA PACIFIC FLUORESCENCE IN-SITU HYBRIDIZATION (FISH) IMAGING SYSTEMS MARKET – REVENUE AND FORECAST TO 2030 – BY PRODUCT

6.1 Overview
6.2 Asia Pacific Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market Revenue Share, by Product 2022 & 2030 (%)
6.3 Instruments
  6.3.1 Overview
  6.3.2 Instruments: Asia Pacific Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market – Revenue and Forecast to 2030 (US$ Million)
    6.3.2.1 Instruments: Asia Pacific Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market – Revenue and Forecast to 2030 (US$ Million)
6.4 Consumables
  6.4.1 Overview
  6.4.2 Consumables: Asia Pacific Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market – Revenue and Forecast to 2030 (US$ Million)
    6.4.2.1 Consumables: Asia Pacific Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market – Revenue and Forecast to 2030 (US$ Million)
6.5 Accessories
  6.5.1 Overview
  6.5.2 Accessories: Asia Pacific Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market – Revenue and Forecast to 2030 (US$ Million)
6.6 Software
  6.6.1 Overview
  6.6.2 Software: Asia Pacific Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market – Revenue and Forecast to 2030 (US$ Million)

7. ASIA PACIFIC FLUORESCENCE IN-SITU HYBRIDIZATION (FISH) IMAGING SYSTEMS MARKET – REVENUE AND FORECAST TO 2030 – BY APPLICATION

7.1 Overview
7.2 Asia Pacific Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market Revenue Share, by Application 2022 & 2030 (%)
7.3 Cancer Diagnosis
  7.3.1 Overview
  7.3.2 Cancer Diagnosis: Asia Pacific Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market – Revenue and Forecast to 2030 (US$ Million)
7.4 Genetic Disease Diagnosis
  7.4.1 Overview
  7.4.2 Genetic Disease Diagnosis: Asia Pacific Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market – Revenue and Forecast to 2030 (US$ Million)
7.5 Infectious Disease Diagnosis
  7.5.1 Overview
  7.5.2 Infectious Disease Diagnosis: Asia Pacific Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market – Revenue and Forecast to 2030 (US$ Million)
7.6 Others
  7.6.1 Overview
  7.6.2 Others: Asia Pacific Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market – Revenue and Forecast to 2030 (US$ Million)

8. ASIA PACIFIC FLUORESCENCE IN-SITU HYBRIDIZATION (FISH) IMAGING SYSTEMS MARKET – REVENUE AND FORECAST TO 2030 – BY END USER

8.1 Overview
8.2 Asia Pacific Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market Revenue Share, by End User 2022 & 2030 (%)
8.3 Diagnostic Laboratories
  8.3.1 Overview
  8.3.2 Diagnostic Laboratories: Asia Pacific Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market – Revenue and Forecast to 2030 (US$ Million)
8.4 Contract Research Organization
  8.4.1 Overview
  8.4.2 Contract Research Organization: Asia Pacific Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market – Revenue and Forecast to 2030 (US$ Million)
8.5 Pharmaceutical and Biotechnological Companies
  8.5.1 Overview
  8.5.2 Pharmaceutical and Biotechnological Companies: Asia Pacific Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market – Revenue and Forecast to 2030 (US$ Million)
8.6 Others
  8.6.1 Overview
  8.6.2 Others: Asia Pacific Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market – Revenue and Forecast to 2030 (US$ Million)

9. ASIA PACIFIC FLUORESCENCE IN-SITU HYBRIDIZATION (FISH) IMAGING SYSTEMS MARKET - COUNTRY ANALYSIS

9.1 Asia Pacific Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market
  9.1.1 Overview
  9.1.2 Asia Pacific Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market, by Country, 2022 & 2030 (%)
    9.1.2.1 China Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market – Revenue and Forecast to 2030 (US$ Million)
      9.1.2.1.1 Overview
      9.1.2.1.2 China Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market – Revenue and Forecast to 2030 (US$ Million)
      9.1.2.1.3 China Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market, by Product, 2020–2030 (US$ Million)
        9.1.2.1.3.1 China Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market, by Instruments, 2020–2030 (US$ Million)
        9.1.2.1.3.2 China Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market, by Consumables, 2020–2030 (US$ Million)
      9.1.2.1.4 China Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market, by Application, 2020–2030 (US$ Million)
      9.1.2.1.5 China Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market, by End User, 2020–2030 (US$ Million)
    9.1.2.2 Japan Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market – Revenue and Forecast to 2030 (US$ Million)
      9.1.2.2.1 Overview
      9.1.2.2.2 Japan Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market – Revenue and Forecast to 2030 (US$ Million)
      9.1.2.2.3 Japan Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market, by Product, 2020–2030 (US$ Million)
        9.1.2.2.3.1 Japan Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market, by Instruments, 2020–2030 (US$ Million)
        9.1.2.2.3.2 Japan Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market, by Consumables, 2020–2030 (US$ Million)
      9.1.2.2.4 Japan Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market, by Application, 2020–2030 (US$ Million)
      9.1.2.2.5 Japan Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market, by End User, 2020–2030 (US$ Million)
    9.1.2.3 India Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market – Revenue and Forecast to 2030 (US$ Million)
      9.1.2.3.1 Overview
      9.1.2.3.2 India Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market – Revenue and Forecast to 2030 (US$ Million)
      9.1.2.3.3 India Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market, by Product, 2020–2030 (US$ Million)
        9.1.2.3.3.1 India Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market, by Instruments, 2020–2030 (US$ Million)
        9.1.2.3.3.2 India Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market, by Consumables, 2020–2030 (US$ Million)
      9.1.2.3.4 India Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market, by Application, 2020–2030 (US$ Million)
      9.1.2.3.5 India Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market, by End User, 2020–2030 (US$ Million)
    9.1.2.4 Australia Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market – Revenue and Forecast to 2030 (US$ Million)
      9.1.2.4.1 Overview
      9.1.2.4.2 Australia Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market – Revenue and Forecast to 2030 (US$ Million)
      9.1.2.4.3 Australia Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market, by Product, 2020–2030 (US$ Million)
        9.1.2.4.3.1 Australia Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market, by Instruments, 2020–2030 (US$ Million)
        9.1.2.4.3.2 Australia Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market, by Consumables, 2020–2030 (US$ Million)
      9.1.2.4.4 Australia Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market, by Application, 2020–2030 (US$ Million)
      9.1.2.4.5 Australia Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market, by End User, 2020–2030 (US$ Million)
    9.1.2.5 South Korea Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market – Revenue and Forecast to 2030 (US$ Million)
      9.1.2.5.1 Overview
      9.1.2.5.2 South Korea Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market – Revenue and Forecast to 2030 (US$ Million)
      9.1.2.5.3 South Korea Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market, by Product, 2020–2030 (US$ Million)
        9.1.2.5.3.1 South Korea Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market, by Instruments, 2020–2030 (US$ Million)
        9.1.2.5.3.2 South Korea Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market, by Consumables, 2020–2030 (US$ Million)
      9.1.2.5.4 South Korea Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market, by Application, 2020–2030 (US$ Million)
      9.1.2.5.5 South Korea Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market, by End User, 2020–2030 (US$ Million)
    9.1.2.6 Rest of Asia Pacific Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market – Revenue and Forecast to 2030 (US$ Million)
      9.1.2.6.1 Overview
      9.1.2.6.2 Rest of Asia Pacific Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market – Revenue and Forecast to 2030 (US$ Million)
      9.1.2.6.3 Rest of Asia Pacific Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market, by Product, 2020–2030 (US$ Million)
        9.1.2.6.3.1 Rest of Asia Pacific Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market, by Instruments, 2020–2030 (US$ Million)
        9.1.2.6.3.2 Rest of Asia Pacific Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market, by Consumables, 2020–2030 (US$ Million)
      9.1.2.6.4 Rest of Asia Pacific Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market, by Application, 2020–2030 (US$ Million)
      9.1.2.6.5 Rest of Asia Pacific Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market, by End User, 2020–2030 (US$ Million)

10. ASIA PACIFIC FLUORESCENCE IN-SITU HYBRIDIZATION (FISH) IMAGING SYSTEMS MARKET INDUSTRY LANDSCAPE

10.1 Overview
10.2 Growth Strategies in the Asia Pacific Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market
10.3 Inorganic Growth Strategies
  10.3.1 Overview
10.4 Organic Growth Strategies
  10.4.1 Overview

11. COMPANY PROFILES

11.1 TissueGnostics GmbH
  11.1.1 Key Facts
  11.1.2 Business Description
  11.1.3 Products and Services
  11.1.4 Financial Overview
  11.1.5 SWOT Analysis
  11.1.6 Key Developments
11.2 Agilent Technologies Inc
  11.2.1 Key Facts
  11.2.2 Business Description
  11.2.3 Products and Services
  11.2.4 Financial Overview
  11.2.5 SWOT Analysis
  11.2.6 Key Developments
11.3 Abnova Taiwan Corp
  11.3.1 Key Facts
  11.3.2 Business Description
  11.3.3 Products and Services
  11.3.4 Financial Overview
  11.3.5 SWOT Analysis
  11.3.6 Key Developments
11.4 BioGenex Laboratories Inc
  11.4.1 Key Facts
  11.4.2 Business Description
  11.4.3 Products and Services
  11.4.4 Financial Overview
  11.4.5 SWOT Analysis
  11.4.6 Key Developments
11.5 Leica Biosystems Nussloch GmbH
  11.5.1 Key Facts
  11.5.2 Business Description
  11.5.3 Products and Services
  11.5.4 Financial Overview
  11.5.5 SWOT Analysis
  11.5.6 Key Developments
11.6 MetaSystems Probes GmbH
  11.6.1 Key Facts
  11.6.2 Business Description
  11.6.3 Products and Services
  11.6.4 Financial Overview
  11.6.5 SWOT Analysis
  11.6.6 Key Developments
11.7 Bio-View Ltd
  11.7.1 Key Facts
  11.7.2 Business Description
  11.7.3 Products and Services
  11.7.4 Financial Overview
  11.7.5 SWOT Analysis
  11.7.6 Key Developments
11.8 Thermo Fisher Scientific Inc
  11.8.1 Key Facts
  11.8.2 Business Description
  11.8.3 Products and Services
  11.8.4 Financial Overview
  11.8.5 SWOT Analysis
  11.8.6 Key Developments
11.9 PerkinElmer Inc
  11.9.1 Key Facts
  11.9.2 Business Description
  11.9.3 Products and Services
  11.9.4 Financial Overview
  11.9.5 SWOT Analysis
  11.9.6 Key Developments
11.10 Euroclone SpA
  11.10.1 Key Facts
  11.10.2 Business Description
  11.10.3 Products and Services
  11.10.4 Financial Overview
  11.10.5 SWOT Analysis
  11.10.6 Key Developments

12. APPENDIX

12.1 About Us
12.2 Glossary of Terms


More Publications